Atlas Trials

Evaluation of the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine

Clinical trial NCT04623034 · COMPLETED

Trial details

NCT number
NCT04623034
Sponsor
MSI Methylation Sciences, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2013-04-17
Primary completion
2013-06-08
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.